Sign in
CompletedNo phase

Parabiotics Use with Nutritional Management in Pediatric Celiac Patients

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
12 Jul 2023
Ended
20 Feb 2025
Type of study
Interventional
Treatments tested
  • Gluten free diet for 3 weeks then parabiotic (Lacteolfort®) for another 3 weeks
Record updated
19 March 2025

Who can take part

Age
2 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Celiac cases diagnosed either by non-biopsy approach {serology based: high IgA antibodies against transglutaminase ≥10 times the upper limit of normal with positive endomysial antibodies or diagnosed by biopsy using March classification

Who cannot take part

  • Patients taking immunosuppressant drugs or antibiotics within the last 4 weeks or during the study
  • Immunocompromised patients

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a sequential study to evaluate the effect of parabiotics as an adjuvant therapy with gluten restriction on quality of life in children with Celiac disease.

The group in the trial

  • Pediatric celiac patientsTreatment being tested

    Strict gluten free food regimen for 3 weeks then parabiotics (Lacteolfort ®) added for another 3 weeks.

    Treatment: Gluten free diet for 3 weeks then parabiotic (Lacteolfort®) for another 3 weeks

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Parabiotics As an Adjuvant in Nutritional Management of Pediatric Celiac Patients
Record updated
19 March 2025